Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine

Nicholas J Loman1, Rebecca A Gladstone, Chrystala Constantinidou

  • 1Centre for Systems Biology, School of Biosciences, University of Birmingham, Birmingham, United Kingdom.

Plos One
|June 1, 2013
PubMed

Insights

The seven-valent pneumococcal conjugate vaccine (PCV7) introduction led to increased Streptococcus pneumoniae serotype 6C carriage. Whole-genome sequencing revealed diverse lineages and vaccine-associated genetic changes.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Streptococcus pneumoniae causes invasive pneumococcal disease, particularly in infants and the elderly.
  • The seven-valent pneumococcal conjugate vaccine (PCV7) reduced disease burden but led to serotype replacement.
  • An increase in serotype 6C carriage was observed following PCV7 introduction.

Purpose of the Study:

  • To investigate the genomic basis for the emergence of Streptococcus pneumoniae serotype 6C.
  • To analyze the genetic diversity and evolutionary dynamics of serotype 6C isolates.
  • To assess potential implications for future pneumococcal conjugate vaccine (PCV) development.

Main Methods:

  • Whole-genome sequencing of 19 Streptococcus pneumoniae serotype 6C isolates (15 carriage, 4 disease).
  • Phylogenetic network analysis to identify distinct lineages and clonal complexes.
  • Comparative genomic analysis of gene sets and sequences, focusing on capsular loci and surface protein genes.

Main Results:

  • Serotype 6C isolates belonged to four distinct phylogenetic lineages within a single geographical site.
  • Variations were identified in the 6C capsular locus and genes encoding surface proteins.
  • Independent capsular switching events introduced the 6C locus into multiple lineages, with rapid clonal expansion in one multi-locus sequence type (MLST) clonal complex 395 (CC395).

Conclusions:

  • The emergence of serotype 6C is driven by multiple capsular switching events and subsequent clonal expansion.
  • Genetic plasticity in vaccine-associated loci poses challenges for current and future pneumococcal conjugate vaccines.
  • Ongoing genomic surveillance and adaptive vaccine design are crucial for sustained protection against invasive pneumococcal disease.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...